Dendritic cells treated with lipopolysaccharide up-regulate serine protease inhibitor 6 and remain sensitive to killing by cytotoxic T lymphocytes in vivo

Journal of Immunology

Volumn 181, Issue 12, 2008, Pages 8356-8362

  Andrew, Kate A ^a   Simkins, Helen M A ^a   Witzel, Sabine ^a,b   Perret, Rachel ^a   Hudson, Jenny ^a   Hermans, Ian F ^a   Ritchie, David S ^a,c   Yang, Jianping ^a   Ronchese, Franca ^a  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; LIPOPOLYSACCHARIDE; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR 6; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; SERINE PROTEINASE; SERPINB9 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IMMUNOMODULATION; IMMUNOREACTIVITY; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL DEATH; CELL STRAIN 3T3; CYTOLOGY; CYTOTOXICITY; ENZYMOLOGY; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; TRANSPLANTATION; UPREGULATION;

ANIMALS; CELL DEATH; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NIH 3T3 CELLS; SERINE ENDOPEPTIDASES; SERPINS; T-LYMPHOCYTES, CYTOTOXIC; UP-REGULATION;

EID: 58849084624     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.12.8356     Document Type: Article

References (30)

1. Guermonprez, P., J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20: 621-667.
2. + T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J. Immunol. 164: 3095-3101.
3. Ritchie, D. S., I. F. Hermans, J. M. Lumsden, C. B. Scanga, J. M. Roberts, J. Yang, R. A. Kemp, and F. Ronchese. 2000. Dendritic cell elimination as an assay of cytotoxic T lymphocyte activity in vivo. J. Immunol. Methods 246: 109-117.
4. + T cells in vivo. Proc. Natl. Acad. Sci. USA 103: 147-152. (Pubitemid 43076119)
5. + T cell. Proc. Natl. Acad. Sci. USA 104: 6341-6346.
6. + T cells enter reactive lymph nodes and kill dendritic cells. Nat. Immunol. 8: 743-752.
7. Medema, J. P., D. H. Schuurhuis, D. Rea, J. van Tongeren, J. de Jong, S. A. Bres, S. Laban, R. E. Toes, M. Toebes, T. N. Schumacher, et al. 2001. Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J. Exp. Med. 194: 657-667.
8. + T cells protect dendritic cells from CTL killing. J. Immunol. 180: 3857-3865.
9. + T cells can protect APC from CTL-mediated elimination. J. Immunol. 176: 7379-7384.
10. Zhang, M., S. M. Park, Y. Wang, R. Shah, N. Liu, A. E. Murmann, C. R. Wang, M. E. Peter, and P. G. Ashton-Rickardt. 2006. Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules. Immunity 24: 451-461.
11. Bladergroen, B. A., M. C. Strik, N. Bovenschen, O. van Berkum, G. L. Scheffer, C. J. Meijer, C. E. Hack, and J. A. Kummer. 2001. The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites. J. Immunol. 166: 3218-3225.
12. Buzza, M. S., C. E. Hirst, C. H. Bird, P. Hosking, J. McKendrick, and P. I. Bird. 2001. The granzyme B inhibitor, PI-9, is present in endothelial and mesothelial cells, suggesting that it protects bystander cells during immune responses. Cell. Immunol. 210: 21-29.
13. Bird, C. H., V. R. Sutton, J. Sun, C. E. Hirst, A. Novak, S. Kumar, J. A. Trapani, and P. I. Bird. 1998. Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol. Cell. Biol. 18: 6387-6398.
14. Waterhouse, N. J., V. R. Sutton, K. A. Sedelies, A. Ciccone, M. Jenkins, S. J. Turner, P. I. Bird, and J. A. Trapani. 2006. Cytotoxic T lymphocyte-induced killing in the absence of granzymes A and B is unique and distinct from both apoptosis and perforin-dependent lysis. J. Cell Biol. 173: 133-144.
15. Bots, M., I. G. Kolfschoten, S. A. Bres, M. T. Rademaker, G. M. de Roo, M. Kruse, K. L. Franken, M. Hahne, C. J. Froelich, C. J. Melief, R. Offringa, and J. P. Medema. 2005. SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicity. Blood 105: 1153-1161.
16. + T cells limits their cytokine synthesis and proliferation. J. Exp. Med. 184: 1543-1547. (Pubitemid 26354711)
17. Pircher, H., K. Burki, R. Lang, H. Hengartner, and R. M. Zinkernagel. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342: 559-561. (Pubitemid 20005822)
18. Garrigan, K., P. Moroni-Rawson, C. McMurray, I. Hermans, N. Abernethy, J. Watson, and F. Ronchese. 1996. Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors. Blood 88: 3508-3512. (Pubitemid 26365586)
19. Kershaw, M. H., C. Hsu, W. Mondesire, L. L. Parker, G. Wang, W. W. Overwijk, R. Lapointe, J. C. Yang, R. F. Wang, N. P. Restifo, and P. Hwu. 2001. Immunization against endogenous retroviral tumor-associated antigens. Cancer Res. 61: 7920-7924.
20. + T cells against tumors. Cancer Immunol. Immunother. 57: 63-71.
21. + T cell responses. J. Immunol. 179: 5738-5747.
22. Simon, M. M., M. Hausmann, T. Tran, K. Ebnet, J. Tschopp, R. ThaHla, and A. Mullbacher. 1997. In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A X B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells. J. Exp. Med. 186: 1781-1786.
23. Heusel, J. W., R. L. Wesselschmidt, S. Shresta, J. H. Russell, and T. J. Ley. 1994. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76: 977-987.
24. Smyth, M. J., S. E. Street, and J. Trapani. 2003. Cutting edge: granzymes A and B are not essential for perforin-mediated tumor rejection. J. Immunol. 171: 515-518.
25. Isaaz, S., K. Baetz, K. Olsen, E. Podack, and G. M. Griffiths. 1995. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway. Eur. J. Immunol. 25: 1071-1079.
26. Ando, K., K. Hiroishi, T. Kaneko, T. Moriyama, Y. Muto, N. Kayagaki, H. Yagita, K. Okumura, and M. Imawari. 1997. Perforin, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J. Immunol. 158: 5283-5291.
27. Kojima, H., N. Shinohara, S. Hanaoka, Y. Someya-Shirota, Y. Takagaki, H. Ohno, T. Saito, T. Katayama, H. Yagita, K. Okumura, et al. 1994. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1: 357-364. (Pubitemid 2134452)
28. Sun, J., C. H. Bird, V. Sutton, L. McDonald, P. B. Coughlin, T. A. De Jong, J. A. Trapani, and P. I. Bird. 1996. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J. Biol. Chem. 271: 27802-27809. (Pubitemid 26367355)
29. Masopust, D., V. Vezys, A. L. Marzo, and L. Lefrançois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413-2417.
30. Heath, W. R., G. T. Belz, G. M. Behrens, C. M. Smith, S. P. Forehan, I. A. Parish, G. M. Davey, N. S. Wilson, F. R. Carbone, and J. A. Villadangos. 2004. Crosspresentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199: 9-26. (Pubitemid 38736761)